Actinium Pharmaceuticals (ATNM) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

External links

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Air Clean Air Act Conservation Contaminant Ecosystem Environment Environmental Forest Hazard Intensity Life Cycle Lifecycle Materials Nature Nuclear Offset Package Packaging Pandemic Pollution Recycling Toxic Waste Access Benefits Black Collective Bargaining Community Customer Cyber Cybersecurity Data Privacy Death Disability Diversity Drug Pricing Employee Engagement Health and Safety Health Care Healthcare Hire Hiring Human Capital Incident Injuries Injury Pay Equity Privacy Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skilled Skills Social Society Stakeholder Supplier Supply Chain Talent Training Union Volunteer Workforce Assessment Assurance Attorneys General Audit Bonus Classified Classified Board Commitment Corporate Governance Corruption Department of Enterprise Risk Management Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Independence Independent Innovation Innovative Investigation Lawsuit Lead Independent Director Leadership Litigant Litigation Long-term Majority Mission Oversee Oversight Plaintiff Pledging Procurement Purpose R&D Reputation Reputational Reputational Risk Research and Development Responsibility Responsible Self-evaluation Strategy Sustainable Targets Tax Transparency Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

A total of 16,495,465 shares of the Company’s common stock were present in person or represented by proxy at the Annual Meeting. Holders of the Company’s common stock were entitled to one vote per share. The following two proposals were submitted to the Company’s stockholders at the Annual Meeting:

(1)	To elect each of David Nicholson and Richard I. Steinhart as a Class I director to serve for a three-year term that expires at the 2026 Annual Meeting of Stockholders, or until his successor is elected and qualified or until his earlier resignation or removal:

Director		For		Withhold		Broker Non-Votes
David Nicholson		3,959,659		3,275,844		9,087,835
Richard I. Steinhart		5,630,379		1,777,251		9,087,835

(2)	To ratify the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023:

For		Against		Abstain		Broker Non-Votes
15,842,146		372,774		280,545		N/A

For more information about the foregoing proposals, see the Proxy Statement, the relevant portions of which are incorporated herein by reference.

The results reported above are final voting results. No other matters were considered or voted upon at the meeting.

1